PMID: 8448084Feb 1, 1993Paper

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors

Annals of Oncology : Official Journal of the European Society for Medical Oncology
H LudwigH Umek

Abstract

Neoplasias, especially in their more advanced stages, are often associated with chronic anemia of malignancy which impairs the patient's physical ability and quality of life. Forty-two patients with chronic anemia associated with hematological malignancies (18 multiple myelomas, 10 myelodysplastic syndromes) or solid tumors (9 breast cancers, 5 colon cancers) were treated with 150-300 units/kg rHuEPO for a median time period of 16 weeks. Response was defined as an increase of the initial hemoglobin level by at least 2 g/dl. The response rates for solid tumors were comparable (44.4% and 40% for breast cancer and colon cancer, respectively), whilst the response in patients with hematological malignancies depended strongly on the disease entity (77.8% for multiple myeloma, 10% for myelodysplastic syndrome). Pretreatment serum levels of endogenous erythropoietin (EPO) were significantly higher in non-responding patients than in responders. During rHuEPO therapy, EPO levels in non-responders increased even further, while they remained basically unchanged in responding patients. In responders, the WHO performance status before the start of rHuEPO therapy was more favorable and showed impressive improvement during the course of treatm...Continue Reading

Citations

Jul 1, 1995·Medical and Pediatric Oncology·M N Beck, D Beck
Aug 5, 1998·International Journal of Clinical & Laboratory Research·F DammaccoL Resegotti
May 7, 1998·Leukemia & Lymphoma·A Ganser, M Karthaus
Aug 1, 1995·Leukemia & Lymphoma·Y Beguin
Apr 1, 1997·European Journal of Haematology·C KasperM R Nowrousian
Mar 1, 1996·Pediatric Hematology and Oncology·I BolonakiM Kalmanti
Aug 20, 2002·The Oncologist·Michael S Gordon
May 1, 2001·British Journal of Haematology·F DammaccoS Rödjer
Sep 29, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigRoscoe F Morton
Nov 1, 1994·Annals of Hematology·U Dührsen, D K Hossfeld
Jun 28, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Philippe FagnoniMarie-Christine Woronoff-Lemsi
Oct 1, 1994·British Journal of Haematology·H SchrezenmeierB Kubanek
Jan 1, 1996·Clinical and Experimental Hypertension : CHE·M A JonesP Sharpstone
Jun 1, 1996·Pediatric Clinics of North America·T C Abshire
May 5, 2006·Health and Quality of Life Outcomes·Robert J NordykeLee S Schwartzberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Revista de neurologia
N Gómez-VieraD Ruiz-García
Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
C Pujol MarcoJ M Fortea Baixauli
© 2021 Meta ULC. All rights reserved